It has been just over a year since Chapman Tripp entered the patent services market with the launch of CT Patents – a strategic move that extended the firm’s market-leading intellectual property practice.
With CT Patents Directors Matt Sumpter and Ben Halberg at the helm, to date CT Patents’ success has been built on work with New Zealand’s leading manufacturer and inventor, Fisher & Paykel Healthcare.
Extending the breadth of expertise in the team, Chapman Tripp appointed David Koedyk as a senior patent attorney at the end of June.
Director of CT Patents, Matt Sumpter said, “David’s skillset further broadens our patents offer across all fields of endeavour, from engineering and chemistry to software and deep tech.”
Koedyk, an intellectual property lawyer and patent attorney specialising in chemistry and materials science, advises clients on patentability, invalidity, infringement and freedom to operate matters. He also has a particular interest in medical devices, advanced materials, food technology, nanotechnology and pharmaceuticals.
“David has developed strong relationships in global patent networks managing patent portfolios for large New Zealand companies, and developing IP strategies and patent protection for new technology developed by New Zealand’s universities, research institutes and start-ups” adds Sumpter.
Chapman Tripp welcomes David to the expanding CT Patents team and looks forward to continuing growth with further patent specialists joining over the coming months.
Koedyk previously worked at a specialist IP firm in Wellington for a number of years and is a Fellow of the New Zealand Institute of Patent Attorneys (NZIPA).